NSC |
Compound |
Enrichment |
Correlation |
NSC 606985 |
Camptothecin Derivative |
3.39349009784534e-005 |
0.7296169 |
NSC 618939 |
Camptothecin Derivative |
3.39349009784534e-005 |
0.74003236 |
NSC 670664 |
Null |
3.39349009784534e-005 |
0.27289548 |
NSC 725774 |
6-[3-(Bis-hydroxyethylamino)-1-propyl]-5,6-dihydro-2,3-~ dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride |
3.39349009784536e-005 |
0.72775074 |
NSC 619003 |
MX2 HCl |
4.54580437744686e-005 |
0.69015752 |
NSC 628665 |
Null |
4.54580437744686e-005 |
0.66828682 |
NSC 744331 |
(2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd |
4.5458043774469e-005 |
0.43735532 |
NSC 58239 |
A 80021F34 |
4.88335076207314e-005 |
0.26817325 |
NSC 166641 |
6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 7-fluoro-2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, monohydrochloride |
4.91939766674006e-005 |
0.47776905 |
NSC 697685 |
Null |
4.91939766674006e-005 |
0.56898369 |